[{"Assets_0_Q3_USD":131890000.0,"CommonStockSharesOutstanding_0_Q3_shares":13110273.0,"EarningsPerShareBasic_1_Q3_USD":0.05,"EarningsPerShareBasic_3_Q3_USD":0.27,"EarningsPerShareDiluted_1_Q3_USD":0.05,"EarningsPerShareDiluted_3_Q3_USD":0.26,"NetIncomeLoss_1_Q3_USD":720000.0,"NetIncomeLoss_3_Q3_USD":3526000.0,"StockholdersEquity_0_Q3_USD":109349000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":13385000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":13404000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":13155000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":13190000.0,"Ticker":"SRDX","CIK":"924717","name":"SURMODICS INC","OfficialName":"Surmodics Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"609353600.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20170803"}]